Highnoon Laboratories Limited (PSX:HINOON)
926.16
0.00 (0.00%)
At close: Apr 3, 2025
Highnoon Laboratories Revenue
In the year 2024, Highnoon Laboratories had annual revenue of 24.63B PKR with 24.60% growth. Highnoon Laboratories had revenue of 6.31B in the quarter ending December 31, 2024, with 34.19% growth.
Revenue
24.63B
Revenue Growth
+24.60%
P/S Ratio
1.97
Revenue / Employee
10.73M
Employees
2,295
Market Cap
48.62B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 24.63B | 4.86B | 24.60% |
Dec 31, 2023 | 19.77B | 3.95B | 24.98% |
Dec 31, 2022 | 15.82B | 2.82B | 21.65% |
Dec 31, 2021 | 13.00B | 2.30B | 21.53% |
Dec 31, 2020 | 10.70B | 1.65B | 18.24% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
GlaxoSmithKline Pakistan | 61.19B |
Abbott Laboratories (Pakistan) | 68.18B |
AGP Limited | 25.03B |
The Searle Company | 28.80B |
Shifa International Hospitals | 25.45B |
Citi Pharma | 13.19B |
Ferozsons Laboratories | 16.82B |
Otsuka Pakistan | 3.37B |